ARS Pharmaceuticals Inc. (SPRY)
NASDAQ: SPRY
· Real-Time Price · USD
14.20
0.23 (1.65%)
At close: May 01, 2025, 3:59 PM
14.21
0.11%
After-hours: May 01, 2025, 05:26 PM EDT
ARS Pharmaceuticals Revenue
ARS Pharmaceuticals reported an annual revenue of $89.15M, reflecting a 297063.33% growth. For the quarter ending December 31, 2024, ARS Pharmaceuticals generated $86.58M in revenue.
Revenue (ttm)
$89.15M
Revenue Growth
297063.33%
Price / Sales Ratio
11.47
Revenue / Employee
$575.15K
Employees
155
Market Cap
1.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 89.15M | +297063.33% |
| Dec 31, 2023 | 30K | -97.72% |
| Dec 31, 2022 | 1.32M | -76.10% |
| Dec 31, 2021 | 5.51M | -69.13% |
| Dec 31, 2020 | 17.84M | n/a |